Effective Surveillance

Antimicrobial resistance (AMR)

AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.

AMR Insights

For Officers at authorities, ministries, international organisations and NGO’s who wish to prevent the further global spreading of Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities. 

AMR Insights is for:

  • Senior officials and (top) civil servants at national authorities
  • Policy Officers at Ministries
  • Civil servants at regional authorities
  • Senior officials at international organizations
  • Senior officials at NGO’s

Latest Topics

  •   23 September 2023

    A new grand bargain to improve the antimicrobial market for human health

    A CGD Working Group Report

  •   22 September 2023

    GLASS manual for antimicrobial resistance surveillance in common bacteria causing human infection

    The purpose of this manual is to provide guidance for countries on the methods and metrics for the
    surveillance of AMR in selected bacteria causing common human infections.

  •   22 September 2023

    CIDRAP-ASP Report – Bringing Value to the Care Pathway: The Rising Role of Rapid Diagnostics

    Outcomes Research & AMR:
    Bringing Value to the Care Pathway: The Rising Role of Rapid Diagnostics


More news related to Effective surveillance

Please call me back

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!